Published in Gene Therapy Weekly, November 2nd, 1998
Several studies have demonstrated that in vivo administration of adenovirus to the brain and visceral organs can induce an inflammatory reaction. Therefore, the use of adenoviral vectors in clinical gene therapy may be limited by toxic effects to surrounding normal tissue.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.